Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 33A is a human protein encoded by the ZNF33A gene, located on chromosome 10. It is predicted to function as a DNA-binding transcription factor, involved in regulating transcription by RNA polymerase II and possibly the transcriptional control of other genes. ZNF33A is part of the zinc finger protein family, which characteristically have zinc finger motifs mediating nucleic acid interactions. Its expression is detected in various human tissues, with cytoplasmic and possibly nuclear localization. ZNF33A has been experimentally shown to interact with ZAK, a serine/threonine-protein kinase, which may modulate its function; ZAK signaling can suppress ZNF33A activity and decrease E2F expression. There is no evidence directly implicating ZNF33A as a therapeutic target, biomarker, or drug-interacting molecule, nor is there documentation of notable safety concerns related to manipulating its activity in humans.
Not applicable (no drugs known to target this protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 33A (ZNF33A).